These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9132622)

  • 61. Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.
    Lin CH; Chen CC; Wang FC; Lane HY
    Psychiatry Clin Neurosci; 2013 May; 67(4):265-72. PubMed ID: 23683158
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE; Stern WC; Van Wyck Fleet J; Reno RM
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Appropriateness of antidepressant treatment for mild depression].
    Himmerich H
    MMW Fortschr Med; 2011 Jul; 153(29-31):31-3. PubMed ID: 21830735
    [No Abstract]   [Full Text] [Related]  

  • 64. An open study of lamotrigine in refractory bipolar depression.
    Kusumakar V; Yatham LN
    Psychiatry Res; 1997 Sep; 72(2):145-8. PubMed ID: 9335206
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A preliminary study of the relationship among personality, cognitive vulnerability, symptom profile, and outcome in major depressive disorder.
    Scott J; Harrington J; House R; Ferrier IN
    J Nerv Ment Dis; 1996 Aug; 184(8):503-5. PubMed ID: 8752080
    [No Abstract]   [Full Text] [Related]  

  • 67. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.
    Nierenberg AA; DeCecco LM
    J Clin Psychiatry; 2001; 62 Suppl 16():5-9. PubMed ID: 11480882
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predicting outcome of lithium added to antidepressants in resistant depression.
    Alvarez E; Pérez-Solá V; Pérez-Blanco J; Queraltó JM; Torrubia R; Noguera R
    J Affect Disord; 1997 Feb; 42(2-3):179-86. PubMed ID: 9105959
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
    Amsterdam JD; Dunner DL; Fabre LF; Kiev A; Rush AJ; Goodman LI
    Pharmacopsychiatry; 1989 Jul; 22(4):137-43. PubMed ID: 2668978
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA; Baldwin DS; Priest RG; Steinert J; Patel A; Herrington RN; Livingston HM
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.
    Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P
    J Clin Psychiatry; 2001; 62 Suppl 22():34-7. PubMed ID: 11599646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database.
    Khan A; Leventhal RM; Khan SR; Brown WA
    J Clin Psychopharmacol; 2002 Feb; 22(1):40-5. PubMed ID: 11799341
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F
    Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A model for handling missing items on two depression rating scales.
    Gale T; Hawley C
    Int Clin Psychopharmacol; 2001 Jul; 16(4):205-14. PubMed ID: 11459334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder.
    Nofzinger EA; Fasiczka A; Berman S; Thase ME
    J Clin Psychiatry; 2000 Nov; 61(11):858-62. PubMed ID: 11105739
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Drug discontinuation in depression].
    Vanelle JM; Féline A
    Encephale; 1994 Apr; 20 Spec No 1():223-9. PubMed ID: 7913680
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.
    Krell HV; Leuchter AF; Morgan M; Cook IA; Abrams M
    J Clin Psychiatry; 2004 Sep; 65(9):1174-9. PubMed ID: 15367043
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The relationship of personality disorders to treatment outcome in depressed outpatients.
    Mulder RT; Joyce PR; Luty SE
    J Clin Psychiatry; 2003 Mar; 64(3):259-64. PubMed ID: 12716266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Should thyroid augmentation precede lithium augmentation--a pilot study.
    Spoov J; Lahdelma L
    J Affect Disord; 1998 Jun; 49(3):235-9. PubMed ID: 9629954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mirtazapine in major depression with comorbid generalized anxiety disorder.
    Goodnick PJ; Puig A; DeVane CL; Freund BV
    J Clin Psychiatry; 1999 Jul; 60(7):446-8. PubMed ID: 10453798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.